Skip to content

Comparison of Different PEEP Titration Strategies Using Electrical Impedance Tomography in Patients With ARDS

Comparison of Different Positive End-expiratory Pressure Titration Strategies Using ELectrical Impedance Tomography in Patients With Acute Respiratory Distress Syndrome : the DELTA Physiological Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04247477
Acronym
DELTA
Enrollment
22
Registered
2020-01-30
Start date
2020-09-22
Completion date
2021-04-08
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Lung Injury, ARDS (Acute Respiratory Distress Syndrome), Electrical Impedance Tomography (EIT), Positive End Expiratory Pressure (PEEP)

Keywords

ARDS, EIT, PEEP titration, Mechanical Ventilation

Brief summary

The aim of the this study is to assess the short term physiological effects of 3 ventilation strategies for adult patients with ARDS admitted to intensive care unit. Two of those strategies are based on electrical impedance tomography (EIT) monitoring.

Interventions

Patients are ventilated in randomized order with three different ventilation strategies (A,B and C)

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

We use a crossover sequential model, with all 3 strategies tested in both arms. A reference strategy, based on the Express method (PEEP level adjusted to reach a plateau pressure of 28-30 cmH2O), is applied at the begining of the study and during a wash-out period (between the 2 periods of application of the 2 EIT-based strategies). The 2 EIT-based strategies are applied in a randomized order.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients with moderate to severe ARDS, defined by the Berlin consensus, at 12 to 48h from diagnosis * PaO2/FiO2 ratio \< 150 mmHg * Patient affiliated to or beneficiary of a health care plan * Consent obtained from patient's SDM

Exclusion criteria

* Pneumothorax * Contraindication to the insertion of a nasogastric tube with an esophageal balloon * Contraindication to the use of Electrical impedance tomography * Pregnancy, lactating or parturient woman

Design outcomes

Primary

MeasureTime frameDescription
Change in PaO2 (mmHg)Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutesAs it is a physiological study, all the outcomes will be analyzed with the same importance!

Secondary

MeasureTime frameDescription
Plateau pressure (cmH2O)Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutesAs it is a physiological study, all the outcomes will be analyzed with the same importance
Positive end expiratory pressure (cmH2O)Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutesAs it is a physiological study, all the outcomes will be analyzed with the same importance
Expiratory and inspiratory transpulmonary pressure (cmH2O)Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutesAs it is a physiological study, all the outcomes will be analyzed with the same importance
Regional ventilation distribution (%)Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutesAs it is a physiological study, all the outcomes will be analyzed with the same importance
Center of ventilation (%)Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutesAs it is a physiological study, all the outcomes will be analyzed with the same importance
Change in PaCO2 (mmHg)Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutesAs it is a physiological study, all the outcomes will be analyzed with the same importance
Global and regional end expiratory lung impedance changes (IU)Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutesAs it is a physiological study, all the outcomes will be analyzed with the same importance
End expiratory lung volume (mL)Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutesAs it is a physiological study, all the outcomes will be analyzed with the same importance
Blood pressure (mmHg)Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutesAs it is a physiological study, all the outcomes will be analyzed with the same importance
Heart rate (bpm)Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutesAs it is a physiological study, all the outcomes will be analyzed with the same importance
Cardiac output (L/min)Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutesAs it is a physiological study, all the outcomes will be analyzed with the same importance
Overdistension and collapsus (%)Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutesAs it is a physiological study, all the outcomes will be analyzed with the same importance

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026